Millennium Management »

Unicycive Therapeutics shares owned by Millennium Management

Quarter-by-quarter ownership of Unicycive Therapeutics (UNCY) shares owned by Millennium Management from 13F filings

Historical chart of Millennium Management investment in Unicycive Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Unicycive Therapeutics held by Millennium Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Unicycive Therapeutics by Millennium Management

Quarter filed Position value Share count Share price at filing
2025-12-31 $5.9M 1.0M 5.77

More positions owned by Millennium Management

Ishares Tr Russell 2000 Etf Call Option (IWM)
Ishares Tr Core S&p500 Etf (IVV)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Apple Put Option (AAPL)
Wal-Mart Stores Call Option (WMT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation Call Option (MSFT)
Amazon (AMZN)
Meta Platforms Cl A (META)
Broadcom Call Option (AVGO)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Tesla Motors (TSLA)
Alphabet Cap Stk Cl C Put Option (GOOG)
Select Sector Spdr Tr State Street Fin (XLF)

View all positions for Millennium Management

Top funds holding Unicycive Therapeutics

Vivo Capital
Millennium Management
Octagon Capital Advisors
Nantahala Capital Management
Dr. Jeffrey R. Jay, M.D.
Vanguard Group
Logos Global Management
Citadel Advisors
Cantor Fitzgerald, L. P.
Geode Capital Management
Bnp Paribas Arbitrage, Snc
Dauntless Investment Group
OMERS Administration Corporation
State Street Corporation
Longwood Capital Partners

View all funds holding Unicycive Therapeutics